β-Blocker Use Not Linked to Reduced Mortality After AMI
No significant difference in mortality for MI patients without HF, LVSD with, without β-blocker use
Risk of Conversion to Multiple Sclerosis Down With Minocycline
Treatment with minocycline reduces conversion to MS over six months after first demyelinating event
Antiretroviral Regimen Adherence Up for Americans With HIV
But too many still stop taking drugs a few years after diagnosis
Three-Drug Combo Pill Nearly 100 Percent Effective in Curing Hep C
Pill (sofosbuvir, velpatasvir, voxilaprevir) is for patients who have failed with direct-acting antivirals
Medication Adherence Up With Refill Synchronization Model
Improvement in medication-taking behavior; cost savings over one year for HTN, DM, hyperlipidemia
Excess Weight Increases Costs Across Health Care Settings
Percentage increases in costs associated with obesity were highest for medications, higher for women
Drug-Resistant Bacteria Seen in Many Nursing Home Residents
More infection-prevention education and policies are needed, researcher says
Gender Minority Adults More Likely to Report Poor Health
Public health professionals need to pay attention to this vulnerable population, researchers say
Restarting Anticoagulation in Certain VTE Cases Cost-Effective
Treating patients with predicted VTE risk of 17.5 percent or more may be cost-effective
Severe Cutaneous Adverse Effect From Tocilizumab Described
Diffuse, persistent, pruritic maculopapular rash developed 10 days after tocilizumab treatment